Skip to main content
padlock icon - secure page this page is secure

Open Access Using genomic technology to understand the origins of lung cancer.

Download Article:
(PDF 468.2 kb)
The Cancer Developmental Biology Lab aims to understand how aberrant activation of embryonic signalling pathways contributes to the initiation, growth and self-renewal of cancer. We use a diverse range of model systems in several different tumour types to create a preclinical research program that has made significant discoveries in cancer biology. These include genetically modified mouse models, and patient-derived xenografts. Key aspects of our research have generated direct translational outcomes in cancer therapy. Most notably, the use of Hedgehog (Hh) pathway inhibitors for the treatment of medulloblastoma is based directly on the work of our laboratory, and that of our international collaborators. By combining data generated from human tissue samples, cell lines and genetic mouse models, we hope to facilitate pathway discovery, and to identify new therapeutic opportunities. More recently, we have begun to dissect the mechanisms behind tumour regeneration, and the genomic origins of acquired resistance to chemotherapy. We undertake research on lung and breast cancers, sarcomas and cancers of childhood.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: October 1, 2017

More about this publication?
  • Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.

  • Subscribe to this Title
  • Terms & Conditions
  • Disseminating research in Impact
  • Information about Impact
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more